this post was submitted on 23 Jun 2023
19 points (100.0% liked)

Science

13025 readers
12 users here now

Studies, research findings, and interesting tidbits from the ever-expanding scientific world.

Subcommunities on Beehaw:


Be sure to also check out these other Fediverse science communities:


This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.

founded 2 years ago
MODERATORS
top 3 comments
sorted by: hot top controversial new old
[–] anji@lemmy.anji.nl 4 points 1 year ago

I hope it really works. Muscular dystrophy is such a bag of dicks. Poor kids.

[–] wjs018 2 points 1 year ago

So, Sarepta has multiple approved therapies that haven't reached positive clinical endpoints? How many times can the agency/drugmaker justify accelerated approval based on an unmet clinical need?

Imo, this just adds to the growing criticism of the agency's growing use of accelerated approvals without holding pharma companies to their post-approval obligations.

[–] Mattol@discuss.tchncs.de 1 points 1 year ago

Interesting discussion in the article. Seems like it's a pretty experimental therapy atm without any conclusive evidence that it works.

load more comments
view more: next ›